comparemela.com

Latest Breaking News On - Samsung bioepis - Page 8 : comparemela.com

EC authorises one of first ustekinumab biosimilars in Europe

EC authorises one of first ustekinumab biosimilars in Europe
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Samsung Biologics Q1 earnings hit all-time high

Samsung Biologics, a leading contract development and manufacturing organization, announced Wednesday that the company’s earnings in the first quarter this year hit an all-time high. In the January-March period, Samsung Biologics’ sales increased by 31.3 percent on-year to 946.9 billion won ($690 million) from the previous year’s 720.9 billion won. Its operating profit also reached 221.3 billion won.

M&M Finance dips 7% as company delays earnings meet on account of Rs 150 cr fraud detected

M&M Finance dips 7% as company delays earnings meet on account of Rs 150 cr fraud detected
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sandoz confirms European Commission nod of Pyzchiva

Basel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab) developed and registered by Samsung Bioepis. Pyzchiva is a key.

Air India enters into codeshare partnership with Japanese airline All Nippon Airways

Air India enters into codeshare partnership with Japanese airline All Nippon Airways
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.